Current NDC auxiliary source row compounder:673

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 26436-5112
Product Ndc: 26436-5112
Product Ndc Digits: 264365112
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Trimix 40/30/3
Proprietary Name Suffix: [empty]
Nonproprietary Name: Trimix 40/30/3
Dosage Form Name: INJECTION
Route Name: INTRACAVERNOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Hybrid Pharma
Establishment Name: Hybrid Pharma
Establishment Fei: [empty]
Substance Name: PAPAVERINE HYDROCHLORIDE; ALPROSTADIL; PHENTOLAMINE MESYLATE
Active Ingredients Info: 30 mg/1 mL; 60 ug/1 mL; 3 mg/1 mL
History Active Ingredients Raw: PAPAVERINE HYDROCHLORIDE; ALPROSTADIL; PHENTOLAMINE MESYLATE
History Active Ingredients Info Raw: 30 mg/1 mL; 60 ug/1 mL; 3 mg/1 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 26436-5112-5
Package Ndc: 26436-5112-5
Package Ndc Digits: 2643651125
Package Ndc11: 26436511205
Package Description: 5 mL in 1 VIAL, MULTI-DOSE (26436-5112-5)
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:673
Source Row Number: 673
Source Row Hash: 5a1c22c193a678e6c4203b2c4b548bc5948f4c2db4052c7201787c1e424a5198
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRACAVERNOUS",
    "PRODUCTNDC": "26436-5112",
    "DEASCHEDULE": "",
    "LABELERNAME": "Hybrid Pharma",
    "SUBSTANCENAME": "PAPAVERINE HYDROCHLORIDE; ALPROSTADIL; PHENTOLAMINE MESYLATE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "26436-5112-5",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Trimix 40/30/3",
    "REPORTINGPERIOD": "2025-1",
    "NONPROPRIETARYNAME": "Trimix 40/30/3",
    "PACKAGEDESCRIPTION": "5 mL in 1 VIAL, MULTI-DOSE (26436-5112-5) ",
    "ACTIVEINGREDIENTSINFO": "30 mg/1 mL; 60 ug/1 mL; 3 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:673
Source Row Number: 673
Status Scope: package
Lookup Ndc: 26436-5112-5
Lookup Ndc Digits: 2643651125
Product Ndc: 26436-5112
Product Ndc Digits: 264365112
Package Ndc: 26436-5112-5
Package Ndc Digits: 2643651125
Package Ndc11: 26436511205
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 5a1c22c193a678e6c4203b2c4b548bc5948f4c2db4052c7201787c1e424a5198
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20